577 related articles for article (PubMed ID: 21900880)
1. Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults.
Brodin-Sartorius A; Tête MJ; Niaudet P; Antignac C; Guest G; Ottolenghi C; Charbit M; Moyse D; Legendre C; Lesavre P; Cochat P; Servais A
Kidney Int; 2012 Jan; 81(2):179-89. PubMed ID: 21900880
[TBL] [Abstract][Full Text] [Related]
2. Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy.
Gahl WA; Balog JZ; Kleta R
Ann Intern Med; 2007 Aug; 147(4):242-50. PubMed ID: 17709758
[TBL] [Abstract][Full Text] [Related]
3. Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
Langman CB; Barshop BA; Deschênes G; Emma F; Goodyer P; Lipkin G; Midgley JP; Ottolenghi C; Servais A; Soliman NA; Thoene JG; Levtchenko EN;
Kidney Int; 2016 Jun; 89(6):1192-203. PubMed ID: 27181776
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients.
Bouazza N; Tréluyer JM; Ottolenghi C; Urien S; Deschenes G; Ricquier D; Niaudet P; Chadefaux-Vekemans B
Orphanet J Rare Dis; 2011 Dec; 6():86. PubMed ID: 22195601
[TBL] [Abstract][Full Text] [Related]
5. Effects of long-term cysteamine treatment in patients with cystinosis.
Ariceta G; Giordano V; Santos F
Pediatr Nephrol; 2019 Apr; 34(4):571-578. PubMed ID: 29260317
[TBL] [Abstract][Full Text] [Related]
6. Intravenous delivery of cysteamine for the treatment of cystinosis: association with hepatotoxicity.
Bendel-Stenzel MR; Steinke J; Dohil R; Kim Y
Pediatr Nephrol; 2008 Feb; 23(2):311-5. PubMed ID: 17668247
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of nephropathic cystinosis: a 20-year single-center experience.
Greco M; Brugnara M; Zaffanello M; Taranta A; Pastore A; Emma F
Pediatr Nephrol; 2010 Dec; 25(12):2459-67. PubMed ID: 20803298
[TBL] [Abstract][Full Text] [Related]
8. Outcome of infantile nephropathic cystinosis depends on early intervention, not genotype: A multicenter sibling cohort study.
Veys K; Zadora W; Hohenfellner K; Bockenhauer D; Janssen MCH; Niaudet P; Servais A; Topaloglu R; Besouw M; Novo R; Haffner D; Kanzelmeyer N; Pape L; Wühl E; Harms E; Awan A; Sikora P; Ariceta G; van den Heuvel B; Levtchenko E
J Inherit Metab Dis; 2023 Jan; 46(1):43-54. PubMed ID: 36117148
[TBL] [Abstract][Full Text] [Related]
9. Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy.
Nesterova G; Williams C; Bernardini I; Gahl WA
Pediatr Nephrol; 2015 Jun; 30(6):945-51. PubMed ID: 25526929
[TBL] [Abstract][Full Text] [Related]
10. [Cystinosis in adults: A systemic disease].
Servais A; Goizet C; Bertholet-Thomas A; Decramer S; Llanas B; Choukroun G; Novo R
Nephrol Ther; 2015 Jun; 11(3):152-9. PubMed ID: 25769364
[TBL] [Abstract][Full Text] [Related]
11. Follow-up and treatment of renal transplantation with nephropathic cystinosis in central Taiwan.
Chuang YW; Wen MC; Wu MJ; Shu KH; Cheng CH; Yu TM; Huang ST; Chen CH
Transplant Proc; 2012 Jan; 44(1):80-2. PubMed ID: 22310585
[TBL] [Abstract][Full Text] [Related]
12. Nephropathic cystinosis in children: An overlooked disease.
Soliman NA; El-Baroudy R; Rizk A; Bazaraa H; Younan A
Saudi J Kidney Dis Transpl; 2009 May; 20(3):436-42. PubMed ID: 19414947
[TBL] [Abstract][Full Text] [Related]
13. Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis.
Kimonis VE; Troendle J; Rose SR; Yang ML; Markello TC; Gahl WA
J Clin Endocrinol Metab; 1995 Nov; 80(11):3257-61. PubMed ID: 7593434
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment of infantile nephropathic cystinosis with cysteamine.
da Silva VA; Zurbrügg RP; Lavanchy P; Blumberg A; Suter H; Wyss SR; Lüthy CM; Oetliker OH
N Engl J Med; 1985 Dec; 313(23):1460-3. PubMed ID: 4058549
[No Abstract] [Full Text] [Related]
15. Switching from immediate- to extended-release cysteamine in nephropathic cystinosis patients: a retrospective real-life single-center study.
Ahlenstiel-Grunow T; Kanzelmeyer NK; Froede K; Kreuzer M; Drube J; Lerch C; Pape L
Pediatr Nephrol; 2017 Jan; 32(1):91-97. PubMed ID: 27350621
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic challenge in a patient with nephropathic juvenile cystinosis: a case report.
Higashi S; Matsunoshita N; Otani M; Tokuhiro E; Nozu K; Ito S
BMC Nephrol; 2017 Sep; 18(1):300. PubMed ID: 28950840
[TBL] [Abstract][Full Text] [Related]
17. Follow-up and treatment of adults with cystinosis in the Netherlands.
Geelen JM; Monnens LA; Levtchenko EN
Nephrol Dial Transplant; 2002 Oct; 17(10):1766-70. PubMed ID: 12270982
[TBL] [Abstract][Full Text] [Related]
18. Early oral cysteamine therapy for nephropathic cystinosis.
Gahl WA
Eur J Pediatr; 2003 Dec; 162 Suppl 1():S38-41. PubMed ID: 14610675
[TBL] [Abstract][Full Text] [Related]
19. Nephropathic cystinosis: late complications of a multisystemic disease.
Nesterova G; Gahl W
Pediatr Nephrol; 2008 Jun; 23(6):863-78. PubMed ID: 18008091
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological treatment of nephropathic cystinosis with cysteamine.
Kleta R; Gahl WA
Expert Opin Pharmacother; 2004 Nov; 5(11):2255-62. PubMed ID: 15500372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]